CD274 and neoplasm: Researchers have constructed patient-derived tumor organoid and exogenous immune cell co-culture systems that not only simulate the inhibitory effects of the PD-1/PD-L1 signaling pathway but also enable accurate quantitative assessments of ICI efficacy by detecting T cell infiltration and cytotoxicity indicators within the organoids (95).